The size of the Latin America Blood Testing Market has been calculated at USD 5.72 billion in 2022. It is further expected to be growing at a CAGR of 2.79% and worth USD 6.56 billion by 2027.
Blood plays a distinctive role in life-saving, but can also be an impending vector for infectious diseases and at times proves to be lethal. With the rising prevalence of diseases, blood is a key biological sample for diagnostic techniques across the globe. Thus, blood testing is significant for diagnostics, in surgeries and for transfusion processes.
The market for blood testing continued to grow under the influence of aging population, rise in incidences of various diseases such as hepatitis, human immunodeficiency virus (HIV) infection, cancer, thyroids, genetic disorders and bacterial and viral allergic disorders, and expanding application of blood testing in other diagnostic areas.
This research report on the Latin America Blood Testing Market has been segmented and sub-segmented into the following categories:
On the basis of region, Mexico is dominating the market and expected to continue its dominance over the forecast period.
Noteworthy companies dominating the Latin America Blood Testing Market profiled in the report are Bio-Rad Laboratories Inc. (U.S.), Siemens Healthcare (Germany), Grifols (Spain), Nanosphere Inc. (U.S.), BioMérieux (France), Dickinson and Company (U.S.), Ortho Clinical Diagnostics Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.) and Beckman Coulter (U.S.).